MARIA ARANZAZU
GOICOLEA ALTUNA
PROFESORADO CATEDRATICO/A DE UNIVERSIDAD
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Centro de Investigacion Biomedica en Red de Salud Mental (10)
2023
-
Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2022
-
A linear-polymer-based lactoferrin-selective recognition element for an ELISA mimic: A proof of concept
Analytica Chimica Acta, Vol. 1191
-
Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods
Microbial Cell Factories, Vol. 21, Núm. 1
-
Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat
Frontiers in Neuroanatomy, Vol. 16
2021
-
Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1
Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502
-
Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis
Microchimica Acta, Vol. 188, Núm. 11
-
Subsynaptic distribution, lipid raft targeting and g protein-dependent signalling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex
Molecules, Vol. 26, Núm. 22
2015
-
Nuclear diacylglycerol lipase-α in rat brain cortical neurons: Evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity
Journal of Neurochemistry, Vol. 132, Núm. 5, pp. 489-503
2013
-
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Neuropharmacology, Vol. 64, pp. 114-123
2012
-
Validation of an LC-ESI-MS/MS method for the quantitation of phosphodiesterase-5 inhibitors and their main metabolites in rat serum and brain tissue samples
Journal of Pharmaceutical and Biomedical Analysis, Vol. 70, pp. 529-533